Correlation Between Talis Biomedical and Icad
Can any of the company-specific risk be diversified away by investing in both Talis Biomedical and Icad at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Talis Biomedical and Icad into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Talis Biomedical Corp and icad inc, you can compare the effects of market volatilities on Talis Biomedical and Icad and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Talis Biomedical with a short position of Icad. Check out your portfolio center. Please also check ongoing floating volatility patterns of Talis Biomedical and Icad.
Diversification Opportunities for Talis Biomedical and Icad
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Talis and Icad is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Talis Biomedical Corp and icad inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on icad inc and Talis Biomedical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Talis Biomedical Corp are associated (or correlated) with Icad. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of icad inc has no effect on the direction of Talis Biomedical i.e., Talis Biomedical and Icad go up and down completely randomly.
Pair Corralation between Talis Biomedical and Icad
If you would invest 178.00 in icad inc on December 24, 2024 and sell it today you would earn a total of 50.00 from holding icad inc or generate 28.09% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Talis Biomedical Corp vs. icad inc
Performance |
Timeline |
Talis Biomedical Corp |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
icad inc |
Talis Biomedical and Icad Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Talis Biomedical and Icad
The main advantage of trading using opposite Talis Biomedical and Icad positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Talis Biomedical position performs unexpectedly, Icad can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Icad will offset losses from the drop in Icad's long position.Talis Biomedical vs. Tivic Health Systems | Talis Biomedical vs. Bluejay Diagnostics | Talis Biomedical vs. Heart Test Laboratories | Talis Biomedical vs. Nuwellis |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |